05/02/2024
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/02/2024
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
04/30/2024
12:11 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
8:47 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/29/2024
8:49 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
|
04/29/2024
8:55 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/26/2024
7:45 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
7:19 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
7:24 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/27/2024
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024
5:00 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
03/18/2024
3:31 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
02/28/2024
3:14 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/28/2024
3:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/28/2024
3:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/23/2024
12:25 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:47 PM | Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Ionic Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
1:42 PM | ARMISTICE CAPITAL, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
1:14 PM | Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
02/12/2024
3:30 PM | Bigger Capital, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024
7:51 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023
11:10 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/28/2023
3:30 PM | Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Cavalry Fund I LP (Filed by)
| Form SC 13G | |
12/26/2023
3:51 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023
3:53 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023
3:53 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/21/2023
3:30 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
3:54 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B4 | |
12/18/2023
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023
4:20 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023
4:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023
3:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
7:57 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
11/27/2023
7:45 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2023
3:06 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
10/03/2023
9:10 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
3:45 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2023
3:23 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023
3:21 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
1970’s computer coder Issues Shocking AI Warning (Ad) Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology…
Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans. Click here to watch his new video ASAP |
07/24/2023
3:22 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023
7:07 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
7:27 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023
3:43 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023
10:52 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/26/2023
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/22/2023
3:33 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2023
3:30 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
06/20/2023
7:16 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023
7:41 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/15/2023
3:51 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
7:35 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
11:15 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/02/2023
5:00 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/01/2023
6:27 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
3:24 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/25/2023
8:53 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/25/2023
8:54 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023
4:25 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023
3:39 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
05/25/2023
3:46 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/24/2023
4:29 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023
8:00 AM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2023
3:21 PM | Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
